Increased/VBN
glucocorticoid/NN
responsiveness/NN
of/IN
CD4+/JJ
T-cell/NN
clonal/JJ
lines/NNS
grown/VBN
in/IN
serum-free/JJ
media/NNS
./.

CEM-C7/NN
,/,
a/DT
human/JJ
leukemic/JJ
CD4+/JJ
T-lymphocyte/NN
cell/NN
line/NN
and/CC
three/CD
of/IN
its/PRP$
subclones/NNS
,/,
CEM-4R4/NN
,/,
CEM-3R43/NN
,/,
and/CC
ICR-27/NN
,/,
previously/RB
cultured/VBN
in/IN
a/DT
medium/NN
supplemented/VBN
with/IN
5/CD
to/TO
10/CD
%/NN
fetal/JJ
bovine/JJ
serum/NN
,/,
have/VBP
been/VBN
adapted/VBN
to/TO
serum-free/JJ
media/NNS
./.
=====
The/DT
best/JJS
medium/NN
of/IN
those/DT
tested/VBN
was/VBD
RPMI/NN
1640/CD
supplemented/VBN
with/IN
5/CD
micrograms/ml/NNS
each/DT
transferrin/NN
and/CC
insulin/NN
+/CC
5/CD
ng/ml/NN
sodium/NN
selenite/NN
+/-/CC
0.1/CD
%/NN
bovine/JJ
serum/NN
albumin/NN
./.
=====
While/IN
growing/VBG
either/CC
with/IN
or/CC
without/IN
albumin/NN
,/,
the/DT
several/JJ
clonal/JJ
lines/NNS
of/IN
CEM/NN
cells/NNS
displayed/VBD
growth/NN
similar/JJ
to/TO
serum-supplemented/JJ
cultures/NNS
./.
=====
Cell/NN
proliferation/NN
of/IN
CEM-C7/NN
cells/NNS
cultured/VBN
in/IN
both/DT
serum-free/JJ
media/NNS
has/VBZ
been/VBN
sustained/JJ
for/IN
3/CD
mo./NN
=====
with/IN
culture/NN
doubling/VBG
times/NNS
of/IN
about/RB
25/CD
h/NN
for/IN
both/CC
serum-supplemented/JJ
and/CC
serum-free/JJ
cultures/NNS
(/(
viability/NN
greater/JJR
than/IN
or/CC
equal/JJ
to/TO
90/CD
%/NN
)/)
./.
=====
Cell/NN
morphology/NN
remained/VBD
essentially/RB
the/DT
same/JJ
in/IN
serum-free/JJ
or/CC
serum/NN
containing/NN
media/NNS
./.
=====
The/DT
expression/NN
of/IN
CD4/NN
,/,
a/DT
marker/NN
for/IN
T-derived/JJ
lymphoid/JJ
cells/NNS
,/,
was/VBD
not/RB
significantly/RB
different/JJ
in/IN
serum-free/JJ
medium/NN
./.
=====
When/WRB
grown/VBN
in/IN
serum-free/JJ
medium/NN
,/,
CEM-C7/NN
cells/NNS
exhibited/VBD
increased/VBN
steroid/NN
responsiveness/NN
as/IN
evidenced/VBN
by/IN
increased/VBN
glucocorticoid/NN
receptor/NN
binding/NN
sites/NNS
,/,
increased/VBN
induction/NN
of/IN
glutamine/NN
synthetase/NN
,/,
and/CC
cell/NN
lysis/NN
at/IN
lower/JJR
concentrations/NNS
of/IN
steroid/NN
./.
=====
Receptor/NN
mutant/NN
subclones/NNS
of/IN
CEM-C7/NN
,/,
which/WDT
are/VBP
proven/VBN
to/TO
be/VB
completely/RB
unresponsive/JJ
to/TO
micromolar/JJ
concentrations/NNS
of/IN
dexamethasone/NN
when/WRB
grown/VBN
in/IN
serum-supplemented/JJ
medium/NN
,/,
become/VBP
partially/RB
sensitive/JJ
to/TO
the/DT
hormone/NN
after/IN
growth/NN
in/IN
defined/VBN
medium/NN
./.
=====
The/DT
increased/VBN
sensitivity/NN
of/IN
CEM-C7/NN
cells/NNS
and/CC
its/PRP$
subclones/NNS
to/TO
dexamethasone/NN
in/IN
serum-free/JJ
medium/NN
returned/VBD
to/TO
previous/JJ
levels/NNS
when/WRB
these/DT
cells/NNS
were/VBD
recultured/VBN
in/IN
serum-containing/JJ
medium/NN
./.
=====
Our/PRP$
results/NNS
suggest/VBP
that/IN
substances/NNS
in/IN
serum/NN
influence/VBP
steroid/NN
effects/NNS
on/IN
these/DT
cells/NNS
and/CC
that/IN
the/DT
molecular/JJ
details/NNS
of/IN
glucocorticoid/NN
hormone/NN
action/NN
may/MD
be/VB
pursued/VBN
more/RBR
precisely/RB
in/IN
a/DT
clearly/RB
defined/VBN
culture/NN
medium/NN
./.